Ticker
LUNGCompany Name
PULMONX CORPSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Total Debt | Shareholders Equity | Invested Capital |
---|---|---|---|
6/30/2025 | $ 56.83M | $ 69.09M | $ 125.92M |
3/31/2025 | $ 56.95M | $ 77.67M | $ 134.62M |
12/31/2024 | $ 56.47M | $ 85.81M | $ 142.28M |
9/30/2024 | $ 55.81M | $ 93.92M | $ 149.73M |
6/30/2024 | $ 56.19M | $ 101.18M | $ 157.37M |
3/31/2024 | $ 40.57M | $ 110.5M | $ 151.07M |
12/31/2023 | $ 41.42M | $ 118.31M | $ 159.74M |
9/30/2023 | $ 42.22M | $ 125.74M | $ 167.96M |
6/30/2023 | $ 42.99M | $ 133.95M | $ 176.94M |
3/31/2023 | $ 43.58M | $ 143.93M | $ 187.51M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt + Equity
(=) Inv. Capital
Inv. Capital for PULMONX CORP is calculated as follows: Debt [ $ 57.23M ] + Equity [ $ -206.89M ]
(=) Inv. Capital [ $ -149.66M ]
Minimum
Sep 30, 2020
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.44K |
---|---|
min | $ -1.51B |
max | $ 4.11B |
average | $ 759.87M |
median | $ 302.55M |
std | $ 1B |